html5-img
1 / 16

A CASE OF MALIGNANT HYPERTENSION

A CASE OF MALIGNANT HYPERTENSION. DR ANN HOLMES GPST2. CASE. Px, 56, c/o loss of central vision R eye, blurred vision L +mild generalised headache.

bian
Télécharger la présentation

A CASE OF MALIGNANT HYPERTENSION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A CASE OF MALIGNANT HYPERTENSION DR ANN HOLMES GPST2

  2. CASE • Px, 56, c/o loss of central vision R eye, blurred vision L +mild generalised headache. • ∆hypertension 5yrs ago but had stopped taking tablets entirely 12/12 ago due to £ issues. Previously on 3 meds but can’t recall names. Feels well otherwise. PMH unremarkable. Smokes 5/day; <14U ETOH • GP refers: BP 200/130, ?papilloedema

  3. Ophthalmoscopy: frank papilloedema-Gd IV hypertensive retinopathy • ECG: LVH • Urine dipstix: protein++++, trace blood • Hb13; ur9,creat240,eGFR14 glucose N LFTs N, neuro exam NAD • Mild leg pitting oedema

  4. Moved to HDU, arterial line, catheterised, labetolol+GTN infusions • Further investigations: cortisol, TFTs, nephritic screen, myeloma screen, urine alb:creat ratio, urgent renal USS+CT head, renin-angiotensinogen levels, urine 24hr metanephrine+catecholamines, lipid profile • Renal, endocrine+ophthalmology teams informed • Renal artery angiography

  5. HDU for 6/7 whilst BP slowly reduced. • Antihypertensives recommenced with omission of ACE inhibitors.

  6. ∆ Malignant hypertension secondary to severe renal artery stenosis: • R 100% occlusion; L 80% • Candidate for possible revascularization • How common is it?

  7. In 1964, Holley et al data from 295 autopsies performed in their institution during a 10-month period.The mean age at death was 61 years. The prevalence rate of renal artery stenosis was 27% of 256 cases identified as having history of hypertension, while 56% showed significant stenosis (>50% luminal narrowing), and, among normotensive patients, 17% had severe renal artery stenosis (>80% luminal narrowing). Among those older than 70 years, 62% had severe renal artery stenosis. Similar results with other studies.

  8. Causes of Renovascular hypoperfusion • Atheroma>90% • Takayasu’s arteritis>60% in Indian subcontinent+Far East • Fibromuscualar hyperplasia • Rarely:PAN,AVM,neurofibramatosis • NB Renal artery stenosis prevalence cauc:black 2:1

  9. Numerous referrals with high BP >180 systolic and headache… • Definition of malignant hypertension?

  10. Severe hypertension with WITH papilloedema + end organ damage • Primary care: Urine dipstix key ?proteinuria+/-blood; ophthalmoscopy. ECG • NOT diagnosed on numbers alone

  11. <1% hypertensives develop: rare • Cause: Essential hypertension in 80% Blacks, 2-30% Caucasians; renal disease the rest • High BPloss of autoregulation; endothelial injury, vascular smooth muscle hypertrophy+collagen depositionluminal narrowing with ischaemia+infarction of end organs • Concurrent pressure triggered natriuresis+SNS stimulationfurther BP • Mortality 90% at 1yr if untreated

  12. NICE hypertension 2011 • Severe hypertension (syst>180 or diastol>110) at diagnosis: • Same day referral if accelerated hypertension with papilloedema/retinal haems + BP>180/110 or suspect phaeochromocytoma • Otherwise assess for end organ damage, don’t wait for ambulatory BP/serial BD home recordings+consider starting treatment with A/C +review

  13. A/C if <55 +C+D;stepwise addition of therapy • Review 1/52ly or sooner post med change for progress aiming for <140/90 if <80 (<150/90 if >80; 130/80 if DM • Then further diuretic/low dose spironolactone dep on K/-blocker if not tolerated • Monitor U+Es within 1/12 • Refer if not controlled on 4 meds

  14. Check compliance • Px education-address lifestyle issues • CVD risk factor assess+manage

  15. references • http://www.patient.co.uk/doctor/Renal-Vascular-Disease.htm • http://emedicine.medscape.com/article/245023-overview • Clinical opthalmology 3rd edn:Kanski p369 • NICE guidelines 2011 hypertension

More Related